Medical devices developer Creo Medical (LON: CREO) has raised £5.5m at 15p/share and the Bank of Wales is subscribing for £2m of convertible loan notes. Creo Medical plans to sell the remaining 49% interest in Creo Medical SL to 51% shareholder CME at book value. The sale of the 51% stake raised £24.7m after costs CME will continue to distribute Creo Medical products in Europe. Cash was £12.4m at the end of 2025 and there was a subsequent dividend of £1.6m from CME. Creo medical made an underlying operating loss of £13.7m on revenues of £6m in 2025 and the additional cash will help to accelerate growth in sales. First quarter revenues were 60% ahead and full year revenues could grow at a similar rate. Operating costs should be reduced by 15%. The share price jumped 28.6% to 14.625p.
FIH Group (LON: FIH) will pay a 40p/share special dividend from the funds from the £11.6m sale of the Portsmouth Harbour Ferry Company. The shares go ex-dividend on 5 June. Chief executive Stuart Munro gets a £478,000 bonus and finance director Reuben Shamu £293,000 for the successful disposal. The share price is one-fifth higher at 270p.
Arkle Resources (LON: ARK) has completed phase 1 geophysics at its Namibian uranium licences. This has defined two distinct mineralisation styles. Drilling on the Eastern EPL 8995 paleochannel target has been accelerated to June. The share price gained 11.5% to 0.725p.
Tapir Holdings (LON: TAPH) independent non-executive director Philip Johnson has bought 85,000 shares at 35p each in the Africa-focused investment company, taking his stake to 0.87%. The share price improved 7.69% to 35p.
FALLERS
Digital media company Catenai (LON: CTAI) has entered a further extension agreement with Klarian, which will repay £699,160 by 1 July. Each additional month after that will incur a 3% fee on the balance not paid. Klarian has entered into a collaborative project for technology in the resources sector. The share price declined 7.41% to 0.25p.
Sound Energy (LON: SOU) expects to commence LNG sales from the Moroccan Tendrara production concession. There was a £1.82m cash outflow from operations in 2025 with a further £3.6m spent on capex and exploration. The company is moving into hydrogen and helium exploration and renewable energy projects. The share price fell 5.99% to 4.55p.
Biomedical polymer medical devices developer RUA Life Sciences (LON: RUA) expects revenues to grow by 6% to £2.8m in the first half. There should be breakeven at the EBITDA level. The share price has risen sharply on the spinning out its structural heart business as RUA Structural Heart and profit-taking has led to a dip of 4.76% to 20p.
Gold producer Metals Exploration (LON: MTL) produced 65,287 ounces of gold in 2025, but the higher gold price meant that revenues rose by 9% to $208.4m. Free cash generated from operations was 19% higher at $115.3m. Construction of the La India project in Nicaragua is one-third complete. The first gold pour could be in December. Gold production guidance for Runruno has been revised downwards to 40,000-48,000 ounces. The share price dropped 4.55% to 13.65p.